Suppr超能文献

经典顺势疗法治疗癌症患者——两项独立队列的前瞻性观察研究。

Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts.

机构信息

Tumour Biology Center at Albert Ludwig's University Freiburg, Germany.

出版信息

BMC Cancer. 2011 Jan 17;11:19. doi: 10.1186/1471-2407-11-19.

Abstract

BACKGROUND

Many cancer patients seek homeopathy as a complementary therapy. It has rarely been studied systematically, whether homeopathic care is of benefit for cancer patients.

METHODS

We conducted a prospective observational study with cancer patients in two differently treated cohorts: one cohort with patients under complementary homeopathic treatment (HG; n = 259), and one cohort with conventionally treated cancer patients (CG; n = 380). For a direct comparison, matched pairs with patients of the same tumour entity and comparable prognosis were to be formed. Main outcome parameter: change of quality of life (FACT-G, FACIT-Sp) after 3 months. Secondary outcome parameters: change of quality of life (FACT-G, FACIT-Sp) after a year, as well as impairment by fatigue (MFI) and by anxiety and depression (HADS).

RESULTS

HG: FACT-G, or FACIT-Sp, respectively improved statistically significantly in the first three months, from 75.6 (SD 14.6) to 81.1 (SD 16.9), or from 32.1 (SD 8.2) to 34.9 (SD 8.32), respectively. After 12 months, a further increase to 84.1 (SD 15.5) or 35.2 (SD 8.6) was found. Fatigue (MFI) decreased; anxiety and depression (HADS) did not change. CG: FACT-G remained constant in the first three months: 75.3 (SD 17.3) at t0, and 76.6 (SD 16.6) at t1. After 12 months, there was a slight increase to 78.9 (SD 18.1). FACIT-Sp scores improved significantly from t0 (31.0 - SD 8.9) to t1 (32.1 - SD 8.9) and declined again after a year (31.6 - SD 9.4). For fatigue, anxiety, and depression, no relevant changes were found. 120 patients of HG and 206 patients of CG met our criteria for matched-pairs selection. Due to large differences between the two patient populations, however, only 11 matched pairs could be formed. This is not sufficient for a comparative study.

CONCLUSION

In our prospective study, we observed an improvement of quality of life as well as a tendency of fatigue symptoms to decrease in cancer patients under complementary homeopathic treatment. It would take considerably larger samples to find matched pairs suitable for comparison in order to establish a definite causal relation between these effects and homeopathic treatment.

摘要

背景

许多癌症患者将顺势疗法作为一种补充疗法。然而,顺势疗法是否对癌症患者有益,这方面的研究还很少。

方法

我们进行了一项前瞻性观察研究,纳入了接受不同治疗的两组癌症患者:一组是接受补充顺势疗法治疗的患者(HG 组,n=259),另一组是接受常规癌症治疗的患者(CG 组,n=380)。为了进行直接比较,我们将为每个患者匹配一组肿瘤实体和预后相似的患者。主要观察指标:接受顺势疗法治疗 3 个月后的生活质量变化(FACT-G、FACIT-Sp)。次要观察指标:接受顺势疗法治疗 1 年后的生活质量变化(FACT-G、FACIT-Sp)、疲劳(MFI)、焦虑和抑郁(HADS)的变化。

结果

HG 组:在最初的 3 个月内,FACT-G 或 FACIT-Sp 分别从 75.6(SD 14.6)提高到 81.1(SD 16.9)或从 32.1(SD 8.2)提高到 34.9(SD 8.32),均有统计学意义。12 个月后,进一步增加到 84.1(SD 15.5)或 35.2(SD 8.6)。疲劳(MFI)下降,焦虑和抑郁(HADS)没有变化。CG 组:FACT-G 在最初的 3 个月内保持不变:t0 时为 75.3(SD 17.3),t1 时为 76.6(SD 16.6)。12 个月后,略有增加至 78.9(SD 18.1)。FACIT-Sp 评分从 t0(31.0- SD 8.9)显著提高到 t1(32.1- SD 8.9),1 年后再次下降。疲劳、焦虑和抑郁均未发现相关变化。HG 组有 120 例患者和 CG 组有 206 例患者符合配对选择标准。然而,由于两组患者之间存在较大差异,仅能形成 11 对配对。这不足以进行比较研究。

结论

在我们的前瞻性研究中,我们观察到接受补充顺势疗法治疗的癌症患者生活质量改善,疲劳症状有下降趋势。为了找到适合比较的配对,需要更大的样本量,以确定这些效果与顺势疗法治疗之间的因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/3035587/b5ec5853c7ee/1471-2407-11-19-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验